UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in ORIC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$687,207
+$271,811 QoQ
Shares Held
54,239
+6.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 47.25382105127307.ToString("F0")%
Shared 0.ToString("F0")%
None 52.74617894872693.ToString("F0")%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. ORIC ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in ORIC
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $687,207 | 54,239 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $415,396 | 50,782 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $278,820 | 23,235 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $2,841,218 | 509,179 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $287,122 | 35,579 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $236,098 | 23,034 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $299,202 | 42,320 | Shares | Defined | 2024-08-14 | |
| 2022-03-31 | $69,596 | 13,033 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $191,584 | 13,033 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $272,519 | 13,033 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $230,552 | 13,033 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $269,500 | 11,000 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $250,490 | 7,400 | Shares | Defined | 2021-03-01 | |
| 2020-06-30 | $430,900 | 12,775 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||